Responsive Web-based Roadmap (InT-mAp) in Infertility Treatment

NCT05890625 | Unknown

• 1 other identifier: 2022/20-02
• Study Type: interventional
• Target: 74
• Locations: 1 country
• Sites: 1

Brief Summary

Infertility affects approximately 48 million couples and 186 million individuals globally, and it has biological, psychosocial, and economic problems in couples. It is a vital global reproductive health problem that has burdens and affects not only families but also society and the state. Studies indicate that many situations experienced during the infertility treatment process negatively affect the treatment results, and the anxiety of individuals receiving treatment, especially women, is high. The previous literature reports that during the infertility treatment process, women experience a decrease in their anxiety and self-confidence about drug administration, they have doubts about the dose, administration, and time of drugs, and the rate of mistakes made regarding drug administration is too high to be ignored. Such cases may lead to cycle cancellations in infertility treatment, interrupting the treatment, adversely affecting the success of the treatment, and thus exposing the couple to more than one treatment trial. The interruption of the treatment with the cycle cancellation, the increase in the number of treatment attempts, the repetitions cause the woman to be exposed to a higher amount of drug, the cost to increase with each treatment trial, an increase in the economic burden of the couples, and an increase in the financial burden for the country. In addition to these physical and economic burdens, feelings such as anxiety, concern, hopelessness, and depression increase in couples, and they may eventually experience burnout. In order to improve the care of infertile individuals, it is clearly stated in the literature that couples need open communication channels with health care professionals, obtaining qualified information, instilling realistic hope, empowerment, accessibility of care services, and they have unmet and high-quality care needs. The increase in the use and use of web-based education services in the globalizing world gives us hope in providing a solution to this issue. This project was mainly designed to answer the question of "Is the responsive web-based roadmap (InT-mAp) developed in solving the problems encountered in drug administration, treatment success and reducing anxiety in infertile women treated with Assisted Reproductive Techniques (ART)?" With InT-mAp, which investigators will develop using web-based education technology, which is a distance education method in this age of technology; investigators aimed to reduce/reduce the margin of error in ART treatment-drug practices, to contribute positively to the treatment process, and to reduce the social, economic and psychological burdens by reducing the anxiety level of individuals in this process. Besides, the InT-mAp, which will be developed to meet individuals' education and counseling needs for general infertility issues and the treatment process, will reduce the workload of healthcare professionals working in this field and make a positive contribution to drug administration consultancy. With this study, investigators aimed to provide participants with time-saving, individualized care, to reach the right information whenever they want, regardless of time and place, on every subject they need in the field of infertility. Investigators predict that sufficient follicle development, healthy oocytes and pregnancy can be achieved by creating awareness in infertile women and minimizing the conditions that may adversely affect the treatment process and results. Contributing to the health and economic indicators of the country by reducing cycle cancellations and reducing costs are among our important goals. The most important features that make the project unique are the absence of online support and a sensitive web-based training platform, where the infertility treatment process in Turkey can be followed in detail by the users, and individualized care and training needs are met.

Conditions

Infertility, Female; Web; Anxiety; IVF

Keywords

infertility; web-based education; drug administration; treatment success; anxiety

Outcome Measures

Primary Outcomes (6)

• Change from Anxiety Level at 12 weeks

  Beck Anxiety Inventory: The minimum score to be taken from the scale is 0, and the maximum score is 63.

  It will be administered before controlled ovarian hyperstimulation treatment and after embryo transfer. (At 0 and approx. at 12 weeks))

• Pregnancy rate

  Human chorionic gonadotropin (B-hCg)

  12 days after embryo transfer (approx. at 13 weeks)

• Treatment success

  Follicle count (Number of follicles formed after controlled ovarian hyperstimulation)

  After controlled ovarian hyperstimulation treatment (at 4 weeks)

• Treatment success

  Oocyte count (Number of oocytes formed after controlled ovarian hyperstimulation)(

  After controlled ovarian hyperstimulation treatment (at 4 weeks)

• Cycle success

  Embryo transfer rate (embryo transfer status)

  After controlled ovarian hyperstimulation treatment (approx. at 12 weeks)

• Nursing Needs of Infertile Women

  Nursing Needs Assessment Scale For Women With Infertility: The lowest score that can be obtained from the scale is 18, and the highest score is 72.

  before the treatment (at 0 week)

Study Arms (2)

InT-mAp

EXPERIMENTAL

Other: InT-mAp

Control group

ACTIVE COMPARATOR

Other: On going treatment

Interventions

On going treatment OTHER

No additional attempts will be made by the investigator on the cases in the control group. These cases will only benefit from the services in the clinic.

Control group

InT-mAp OTHER

InT-mAp, the content of which will be created as a result of the evaluation of the nursing needs of infertile women, consists of a web-based training and online consultancy platform. The treatment plan specific to each participant will be entered into the web base individually, and the participants will be able to follow and manage the treatment protocols and appointments under their own control. InT-mAp is a guide that helps breakers about the intended use, effects, side effects of the drugs under treatment and how to self-administer, especially for women.

InT-mAp

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• In vitro fertilization-Embryo transfer (IVF-ET)/ Intracytoplasmic Sperm Injection (ICSI)-ET treatment planned as assisted reproduction treatment (ART) and who are in the controlled ovarian hyperstimulation (COS) process of the treatment,
• Having no psychological or chronic illness and related treatment that may affect the success of treatment other than the cause of infertility,
• Primary infertile,
• Being under 35 years old,
• Able to speak, read and write Turkish, perceive and answer questions correctly and communicate effectively,
• Having a smart phone with Android and the operating system for i-Phone (IOS) operating systems, being able to use mobile applications, and having sufficient equipment to use these applications (internet, etc.),
• Women who volunteered to participate in the study will be included in the sample.

You may not qualify if:

• Not meeting the sampling criteria,
• Wanting to leave after the start of work,
• Women with errors or deficiencies in their evaluation/use of the mobile application will be excluded from the study.

Sponsors & Collaborators

• Maltepe University: lead
• Marmara University: collaborator

Study Sites (1)

SBÜ Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Infertility, Female; Anxiety Disorders; Infertility

Condition Hierarchy (Ancestors)

Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Mental Disorders

Central Study Contacts

Tugba Bozdemir

CONTACT

+90 5520978860; tugbabozdemir@maltepe.edu.tr

Hatice Yildiz

CONTACT

+905323926429; hatice.hy@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer

Study Record Dates

• First Submitted: May 18, 2023
• First Posted: June 6, 2023
• Study Start: June 10, 2023
• Primary Completion: December 29, 2023
• Study Completion: February 1, 2024
• Last Updated: November 21, 2023

Record last verified: 2023-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)